Insilico's Pharma.AI fall 2026 release adds specialized models and AI agents
The fall update of the Pharma.AI platform brings specialized models and AI agents to drug discovery and development. A summary of the release was published on 14 October.
Who is affected and how
- pharmaceuticals
- The platform update points toward agent-based workflows and is worth comparing with companies' existing tool stacks.
Sources
- Pharma.AI Fall 2026 Release Recap: Transforming Drug Discovery and Development Through Specialized Models and AI Agentsinsilico medicine · Oct 14, 2026
- MLOps in Healthcare and Pharma: Governing Models in 2026intuceo.com · Oct 14, 2026
- AI in drug discovery & development: News watch, October 2026pharmaphorum · Oct 16, 2026
- 13 AI drug discovery companies you need to watch in 2025labiotech.eu · Oct 16, 2026
- AI in drug discovery & development: News watch, October 2026 | pharmaphorumpharmaphorum.com · Oct 16, 2026
- FAQ: What You Need to Know About Agentic AI in Drug Discovery | BioPharm Internationalbiopharminternational.com · Oct 17, 2026
- Pharma.AI 2026 秋季发布回顾：以专业模型与 AI 智能体重构新药研发insilico.com · Oct 13, 2026 · magyar
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.